will be just what the doctor ordered, however, the right fit is very difficult to find / at the right price / anything close to Novazyme would really propel us up up and away / but that's a long shot unless we find a fit that is strapped for cash cash! ......so probably another little deal in the next half of the year.
all tech analysis and especially the 10/50 EMA cross over are meaningful - great heads up.
If the 10 EMA can cross over the 50 day EMA then this stock should continue to rise adn test the $24 highs.
do we touch last weeks low / fill the small gap and move onward and upward or breach support and then trend down a bit to $15 ish??
....yep RGEN finally corrected.....do we see support at $18?.....the volume was not huge but down down down....with the low float and volume it doesn't take much on the institutional side to impact share price so someone wanted or needed to take profits.....even if 18 or 19 is the bottom do not see much more down down down......and imagine we create a base and level off soon.
quant, I think it is a strong investment for the future. tending low for now due to rebalancing and possible profit taking by few. significant positive trend in the future for sure.
guidance is strong......3 growth areas.....cash for more acquisitions / $3M net annually......not counting
any future royalties from BioMarin and the other......strong growth ......
could not expect more.
Was concerned we could miss and lose $1-$2 per share - did not look at the numbers yet but this is really encouraging and the guidance appears strong......we are on firm ground unless all ships are taken down by a correction....feeling very very positive moving forward.
Well after up up up up this was to be accepted / if we can hold $20 / base in low $20's then up up and back to $25 - $26 that would be great.